Phase 3 Multiple Sclerosis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 18 years or older
- People who are able to read and speak in English or Spanish
- People who are willing and able to give their informed consent to take part
- People who have been diagnosed with Multiple Sclerosis (MS)
- People who are about to start, or are currently receiving, one of these medications: ocrelizumab, ublituximab, or rituximab
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are unable or unwilling to give their consent to take part
- People under 18 years of age
- People who are pregnant
- People who have had an allergic reaction to cetirizine, any of its ingredients, or a related medication called hydroxyzine
- People with moderate or severe kidney problems (confirm with trial site)
- People who have had previous allergic reactions to their infusion medication that required extra preventative medications the night before an infusion (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jeffrey Hernandez, DNP, APRN, University of Miami
Phone: 305-243-8873
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Tolerability as Measured by Sleepiness (Stanford Sleepiness Scale)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.